Fresenius Medical Care AG & Co KGaA (FMS)
50.30USD
9 Feb 2010
$0.68 (+1.37%)
$49.62
$49.91
$50.58
$49.50
55,652
62,125
$55.31
$34.30
FMS
About
Overall
| Beta: | 0.56 |
| Market Cap (Mil.): | $14,622.56 |
| Shares Outstanding (Mil.): | 294.69 |
| Annual Dividend: | 0.79 |
| Yield (%): | 1.59 |
Financials
| FMS | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 17.26 | 9.88 | 3.76 |
| EPS (TTM): | 6.32 | -- | -- |
| ROI: | 7.55 | 3.98 | 2.30 |
| ROE: | 13.81 | -33.52 | 2.82 |
German stocks - Factors to watch on January 25
FRANKFURT, Jan 25 (Reuters) - The DAX top-30 index looked set to open 1.3 percent lower on Monday, according to premarket data from brokers at 0712 GMT.
German stocks - Factors to watch on January 25
FRANKFURT, Jan 25 (Reuters) - The following are some of the factors that may move German stocks on Monday:
Germany's FMC to manage 12 British dialysis units
FRANKFURT, Jan 11 (Reuters) - Fresenius Medical Care AG has been selected by Britain's National Health Service to manage dialysis care for 12 renal units, the company said on Friday.
OFFICIAL-CORRECTED-US FDA clears Fresenius drug for blood loss
(Official correction from U.S. FDA noting maker of Hespan is B. Braun Medical, not Abbott Laboratories, in paragraph 4)
UPDATE 3-Deals of the day -- mergers and acquisitions
Nov 29 (Reuters) - The following bids, mergers, acquisitions and disposals involving European, U.S. and Asian companies were reported by 2115 GMT on Thursday.
FMC acquires Renal Solutions for $190 mln
FRANKFURT, Nov 29 (Reuters) - Germany's Fresenius Medical Care bought Renal Solutions for up to $190 million to strengthen its dialysis business, FMC said on Thursday.
Fresenius may conclude removab talks early 2008
FRANKFURT, Oct 31 (Reuters) - Fresenius SE is looking to conclude talks with potential marketing partners for experimental cancer drug removab early next year, Chief Executive Ulf Schneider said on Wednesday.
European Factors -- Stocks seen steady, Fed decision tops agenda
LONDON, Oct 31 (Reuters) - European equities are set to open little changed on Wednesday, with the focus on the Federal Reserve's verdict on interest rates and a raft of results led by Deutsche Bank and Sanofi Aventis .
Fresenius Medical Care's Q3 profit rises 14 percent
FRANKFURT, Oct 30 (Reuters) - Fresenius Medical Care (FMC) posted a 14 percent rise in its third-quarter operating profit on Tuesday, thanks to acquisitions and higher treatment prices.
Eurostocks Weekahead-Fed rate decision, key earnings in focus
FRANKFURT, Oct 26 (Reuters) - The U.S. Federal Reserve's interest rate decision will be in the limelight next week, competing for investors' attention with a slew of earnings updates from top European companies and key economic data.
Competitors
| Price | Change | |
|---|---|---|
| Dialysis Corporation of America (DCAI.OQ) | $6.51 | +0.08 |
| DaVita Inc. (DVA.N) | $61.20 | +1.14 |
| Baxter International Inc. (BAX.N) | $56.38 | +0.02 |
| ASAHI KASEI CORPORATION (3407.T) | ¥456.00 | +1.00 |
| NIPRO CORPORATION (8086.T) | ¥1,827.00 | -9.00 |
| NIKKISO CO., LTD. (6376.T) | ¥541.00 | +4.00 |
| TERUMO CORPORATION (4543.T) | ¥4,860.00 | -15.00 |
| Kawasumi Laboratories, Incorporated (7703.T) | ¥598.00 | 0.00 |
| Fuso Pharmaceutical Industries, Ltd. (4538.T) | ¥280.00 | 0.00 |
| TORAY INDUSTRIES, INC. (3402.T) | ¥489.00 | -4.00 |
Earnings vs 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
